Skip to main content
Article thumbnail
Location of Repository

A Novel Immune Evasion Strategy of Candida albicans: Proteolytic Cleavage of a Salivary Antimicrobial Peptide

By Timothy F. Meiller, Bernhard Hube, Lydia Schild, Mark E. Shirtliff, Mark A. Scheper, Robert Winkler, Amy Ton and Mary Ann Jabra-Rizk

Abstract

Oropharyngeal candidiasis is an opportunistic infection considered to be a harbinger of AIDS. The etiologic agent Candida albicans is a fungal species commonly colonizing human mucosal surfaces. However, under conditions of immune dysfunction, colonizing C. albicans can become an opportunistic pathogen causing superficial or even life-threatening infections. The reasons behind this transition, however, are not clear. In the oral cavity, salivary antimicrobial peptides are considered to be an important part of the host innate defense system in the prevention of microbial colonization. Histatin-5 specifically has exhibited potent activity against C. albicans. Our previous studies have shown histatin-5 levels to be significantly reduced in the saliva of HIV+ individuals, indicating an important role for histatin-5 in keeping C. albicans in its commensal stage. The versatility in the pathogenic potential of C. albicans is the result of its ability to adapt through the regulation of virulence determinants, most notably of which are proteolytic enzymes (Saps), involved in tissue degradation. In this study, we show that C. albicans cells efficiently and rapidly degrade histatin-5, resulting in loss of its anti-candidal potency. In addition, we demonstrate that this cellular activity is due to proteolysis by a member of the secreted aspartic proteases (Sap) family involved in C. albicans pathogenesis. Specifically, the proteolysis was attributed to Sap9, in turn identifying histatin-5 as the first host-specific substrate for that isoenzyme. These findings demonstrate for the first time the ability of a specific C. albicans enzyme to degrade and deactivate a host antimicrobial peptide involved in the protection of the oral mucosa against C. albicans, thereby providing new insights into the factors directing the transition of C. albicans from commensal to pathogen, with important clinical implications for alternative therapy. This report characterizes the first defined mechanism behind the enhanced susceptibility of HIV+ individuals to oral candidiasis since the emergence of HIV

Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:2661360
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. (2001). A review of saliva: normal composition, flow, and function.
    2. (1997). A triple deletion of the secreted aspartyl proteinase genes SAP4, SAP5,a n dSAP6 of Candida albicans causes attenuated virulence.
    3. (2008). Activation mechanism, functional role and shedding of glycosylphosphatidylinositolanchored Y ps 1 p at the Saccharomyces cerevisiae cell surface.
    4. (2002). Anti-fungal therapy at the HAART of viral therapy.
    5. (2001). Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance.
    6. (2004). Candida albicans proteinases and host/pathogen interactions.
    7. (2003). Candida albicans secreted aspartyl proteinases in virulence and pathogenesis.
    8. (1996). Candida albicans secreted aspartyl proteinases.
    9. (2003). Candida albicans Ssa1/2p is the cell envelope binding protein for human salivary histatin 5.
    10. (2002). Candida and Candidiasis.
    11. (2006). Candida-host interactions in HIV disease: relationships in oropharyngeal candidiasis.
    12. (1998). Candidacidal activity of salivary histatins.
    13. (2000). Differential activation of a Candida albicans virulence gene family during infection.
    14. (1997). Disruption of each of the secreted aspartyl proteinase genes SAP1, SAP2,a n dSAP3 of Candida albicans attenuates virulence.
    15. (2007). Dongari-Bagtzoglou A
    16. (1996). Elevated aspartic proteinase secretion and experimental pathogenicity of Candida albicans isolates from oral cavities of subjects infected with human immunodeficiency virus.
    17. (2007). Epidemiology of invasive candidiasis: a persistent public health problem.
    18. (1990). Evidence that members of the secretory aspartyl proteinases gene family (SAP), in particular SAP2, are virulence factors for Candida vaginitis.
    19. (2006). Glycosylphosphatidylinositol-anchored proteases of Candida albicans target proteins necessary for both cellular processes and hostpathogen interactions.
    20. (1988). Histatins, a novel family of histidine-rich proteins in human parotid secretion.
    21. (2004). Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection.
    22. (2002). Individual acidic aspartic proteinases (Saps)1-6 of Candida albicans are not indispensable for invasion and colonisation of the gastrointestinal tract in mice.
    23. (2006). Infection-associated gene of Candida albicans.
    24. (2007). Infection-related gene expression in Candida albicans.
    25. (2003). Internalisation and degradation of histatin 5 by Candida albicans.
    26. (2001). Killing of Candida albicans by histatin 5: cellular uptake and energy requirement.
    27. (1992). Longitudinal study of parotid saliva in HIV-1 infection.
    28. (2008). Niche-specific gene expression during C. albicans infection.
    29. (2007). Nosocomial fungal infections: epidemiology, diagnosis, and treatment.
    30. (1984). Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome.
    31. (1999). Oral colonization by Candida albicans.
    32. (2006). Oral fluid proteolytic effects on histatin 5 structure and function.
    33. (1992). Pilot study comparing the salivary cationic protein concentrations in healthy adults and AIDS patients: correlation with antifungal activity.
    34. (2008). Quantitative expression of the Candida albicans secreted aspartyl proteinase gene family in human oral and vaginal candidiasis.
    35. (2000). Released ATP is an extracellular cytotoxic mediator in salivary histatin 5-induced killing of Candida albicans.
    36. (1992). Saliva: its secretion, composition and functions.
    37. (1999). Salivary histatin 5 induces non-lytic release of ATP from Candida albicans leading to cell death.
    38. (2008). Salivary Histatin-5 and oral fungal colonization in HIV+ individuals.
    39. (1993). Salivary proteolysis of histidinerich polypeptides and the antifungal activity of peptide degradation products.
    40. (2008). The antimicrobial peptide histatin-5 causes a spatially restricted disruption on the Candida albicans surface allowing rapid entry of the peptide into the cytoplasm.
    41. (1999). The cellular target of histatin 5 on Candida albicans is the energized mitochondrion.
    42. (1998). The expression of the secreted aspartyl proteinases Sap4 to Sap6 from Candida albicans in murine macrophages.
    43. (2001). The human salivary peptide histatin 5 exerts its antifungal activity through the formation of reactive oxygen species.
    44. (1998). The relationship between salivary histatin levels and oral yeast carriage.

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.